Barinthus Biotherapeutics Financial Overview
Barinthus Biotherapeutics's market cap is currently $28.64M. The company's EPS TTM is $-0.36; its P/E ratio is -0.37; Barinthus Biotherapeutics is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
